About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 390714, 11 pages
http://dx.doi.org/10.1155/2013/390714
Research Article

A Combination of Radiosurgery and Soluble Tissue Factor Enhances Vascular Targeting for Experimental Glioblastoma

1Australian School of Advanced Medicine, Macquarie University, 2 Technology Place, North Ryde, Sydney, NSW 2109, Australia
2Department of Neurosurgery, The 9th Medical Clinical College of Beijing University, Beijing 100850, China
3Department of Electromagnetic and Laser Biology, Beijing Institute of Radiation Medicine, Beijing 100038, China

Received 28 April 2013; Accepted 25 September 2013

Academic Editor: Pasquale F. Innominato

Copyright © 2013 Jian Tu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Rosenthal, K. J. Drummond, M. Dally et al., “Management of glioma in Victoria (1998-2000): retrospective cohort study,” Medical Journal of Australia, vol. 184, no. 6, pp. 270–273, 2006. View at Scopus
  2. N. G. Burnet, S. J. Jefferies, R. J. Benson, D. P. Hunt, and F. P. Treasure, “Years of life lost (YLL) from cancer is an important measure of population burden and should be considered when allocating research funds,” British Journal of Cancer, vol. 92, no. 2, pp. 241–245, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Y. Wen and S. Kesari, “Malignant gliomas in adults,” The New England Journal of Medicine, vol. 359, no. 5, pp. 492–507, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. N. Sarkaria, G. J. Kitange, C. D. James et al., “Mechanisms of chemoresistance to alkylating agents in malignant glioma,” Clinical Cancer Research, vol. 14, no. 10, pp. 2900–2908, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. P. E. Thorpe, “Vascular targeting agents as cancer therapeutics,” Clinical Cancer Research, vol. 10, no. 2, pp. 415–427, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. G. M. Tozer, S. M. Ameer-Beg, J. Baker et al., “Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy,” Advanced Drug Delivery Reviews, vol. 57, no. 1, pp. 135–152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Konerding, W. Malkusch, B. Klapthor et al., “Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts,” British Journal of Cancer, vol. 80, no. 5-6, pp. 724–732, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. R. J. Gillies, P. A. Schornack, T. W. Secomb, and N. Raghunand, “Causes and effects of heterogeneous perfusion in tumors,” Neoplasia, vol. 1, no. 3, pp. 197–207, 1999. View at Scopus
  9. A. Eberhard, S. Kahlert, V. Goede, B. Hemmerlein, K. H. Plate, and H. G. Augustin, “Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies,” Cancer Research, vol. 60, no. 5, pp. 1388–1393, 2000. View at Scopus
  10. H. Hashizume, P. Baluk, S. Morikawa et al., “Openings between defective endothelial cells explain tumor vessel leakiness,” The American Journal of Pathology, vol. 156, no. 4, pp. 1363–1380, 2000. View at Scopus
  11. J. Tu, M. A. Stoodley, M. K. Morgan, and K. P. Storer, “Ultrastructure of perinidal capillaries in cerebral arteriovenous malformations,” Neurosurgery, vol. 58, no. 5, pp. 961–969, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. He, Y. Yin, T. A. Luster, L. Watkins, and P. E. Thorpe, “Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma,” Clinical Cancer Research, vol. 15, no. 22, pp. 6871–6880, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. He, T. A. Luster, and P. E. Thorpe, “Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids,” Clinical Cancer Research, vol. 13, no. 17, pp. 5211–5218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Huang, M. Bennett, and P. E. Thorpe, “A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice,” Cancer Research, vol. 65, no. 10, pp. 4408–4416, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Ran, A. Downes, and P. E. Thorpe, “Increased exposure of anionic phospholipids on the surface of tumor blood vessels,” Cancer Research, vol. 62, no. 21, pp. 6132–6140, 2002. View at Scopus
  16. S. Ran, J. He, X. Huang, M. Soares, D. Scothorn, and P. E. Thorpe, “Anti-tumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice,” Clinical Cancer Research, vol. 11, no. 4, pp. 1551–1562, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Jennewein, M. A. Lewis, D. Zhao et al., “Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine,” Clinical Cancer Research, vol. 14, no. 5, pp. 1377–1385, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Storer, J. Tu, A. Karunanayaka et al., “Coadministration of low-dose lipopolysaccharide and soluble tissue factor induces thrombosis after radiosurgery in an animal arteriovenous malformation model,” Neurosurgery, vol. 61, no. 3, pp. 604–611, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Sammons, A. Davidson, J. Tu, and M. A. Stoodley, “Endothelial cells in the context of brain arteriovenous malformations,” Journal of Clinical Neuroscience, vol. 18, no. 2, pp. 165–170, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. K. P. Storer, J. Tu, A. Karunanayaka, M. K. Morgan, and M. A. Stoodley, “Thrombotic molecule expression in cerebral vascular malformations,” Journal of Clinical Neuroscience, vol. 14, no. 10, pp. 975–980, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. K. P. Storer, J. Tu, A. Karunanayaka, M. K. Morgan, and M. A. Stoodley, “Inflammatory molecule expression in cerebral arteriovenous malformations,” Journal of Clinical Neuroscience, vol. 15, no. 2, pp. 179–184, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Karunanyaka, J. Tu, A. Watling, K. P. Storer, A. Windsor, and M. A. Stoodley, “Endothelial molecular changes in a rodent model of arteriovenous malformation: laboratory investigation,” Journal of Neurosurgery, vol. 109, no. 6, pp. 1165–1172, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. K. P. Storer, A. Karunanayaka, J. Tu, R. Smee, A. Watling, and M. A. Stoodley, “Identification of potential molecular targets for directed thrombosis after radiosurgery in an animal arteriovenous malformation model,” Neurosurgery, vol. 58, no. 2, pp. 403–404, 2006.
  24. J. Tu, M. A. Stoodley, M. K. Morgan, and K. P. Storer, “Responses of arteriovenous malformations to radiosurgery: ultrastructural changes,” Neurosurgery, vol. 58, no. 4, pp. 749–758, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Liu, V. Sammons, J. Fairhall, et al., “Molecular responses of brain endothelial cells to radiation,” Journal of Clinical Neuroscience, vol. 19, no. 8, pp. 1154–1158, 2012.
  26. Z. Hu, Y. Xing, Y. Qian, et al., “Anti-radiation damage effect of polyethylenimine as a toll-like receptor 5 targeted agonist,” Journal of Radiation Research, vol. 54, no. 2, pp. 243–250, 2013.
  27. E. W. Newcomb and D. Zagzag, “The murine GL261 glioma experimental model to assess novel brain tumor treatment,” in CNS Cancer, Cancer Drug Discovery and Development, E. G. van Meir, Ed., vol. 1, pp. 227–241, 2009. View at Publisher · View at Google Scholar
  28. National Health and Medical Research Council, Australian Code of Practice for the Care and Use of Animals for Scientific Purposes, 7th edition, 2004.
  29. J. L. Hintze, “Analysis of variance,” in Number Cruncher Statistical Systems (NCSS) 97-User’s Guide-I, pp. 205–278, J. L. Hintze, Kaysville, Utah, USA, 1997.
  30. N. E. A. Crompton, “Telomeres, senescence and cellular radiation response,” Cellular and Molecular Life Sciences, vol. 53, no. 7, pp. 568–575, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Cohen-Jonathan, E. J. Bernhard, and W. G. McKenna, “How does radiation kill cells?” Current Opinion in Chemical Biology, vol. 3, no. 1, pp. 77–83, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. M. F. Milosevic, A. W. Fyles, and R. P. Hill, “The relationship between elevated interstitial fluid pressure and blood flow in tumors: a bioengineering analysis,” International Journal of Radiation Oncology Biology Physics, vol. 43, no. 5, pp. 1111–1123, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. L. F. Fajardo and M. Berthrong, “Vascular lesions following radiation,” Pathology Annual, vol. 23, part 1, pp. 297–330, 1988. View at Scopus
  34. G. S. Dimitrievich, K. Fischer-Dzoga, and M. L. Griem, “Radiosensitivity of vascular tissue. I. Differential radiosensitivity of capillaries: a quantitative in vivo study,” Radiation Research, vol. 99, no. 3, pp. 511–535, 1984. View at Scopus
  35. L. F. Fajardo, “Is the pathology of radiation injury different in small vs large blood vessels?” Cardiovascular Radiation Medicine, vol. 1, no. 1, pp. 108–110, 1999. View at Scopus
  36. T. Kamiryo, M. B. S. Lopes, N. F. Kassell, L. Steiner, and K. S. Lee, “Radiosurgery-induced microvascular alterations precede necrosis of the brain neuropil,” Neurosurgery, vol. 49, no. 2, pp. 409–415, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. M. M. O'Connor and M. R. Mayberg, “Effects of radiation on cerebral vasculature: a review,” Neurosurgery, vol. 46, no. 1, pp. 138–151, 2000. View at Scopus
  38. F. Paris, Z. Fuks, A. Kang et al., “Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice,” Science, vol. 293, no. 5528, pp. 293–297, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. B. C. Baguley, “Antivascular therapy of cancer: DMXAA,” The Lancet Oncology, vol. 4, no. 3, pp. 141–148, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. X. Huang, G. Molema, S. King, L. Watkins, T. S. Edgington, and P. E. Thorpe, “Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature,” Science, vol. 275, no. 5299, pp. 547–550, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. H. H. Sedlacek, “Pharmacological aspects of targeting cancer gene therapy to endothelial cells,” Critical Reviews in Oncology/Hematology, vol. 37, no. 3, pp. 169–215, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. P. E. Thorpe, D. J. Chaplin, and D. C. Blakey, “The first international conference on vascular targeting: meeting overview,” Cancer Research, vol. 63, no. 5, pp. 1144–1147, 2003. View at Scopus
  43. R. A. Brekken and P. E. Thorpe, “Vascular endothelial growth factor and vascular targeting of solid tumors,” Anticancer Research, vol. 21, no. 6, pp. 4221–4229, 2001. View at Scopus
  44. C. Carpenito, P. D. Davis, S. T. Dougherty, and G. J. Dougherty, “Exploiting the differential production of angiogenic factors within the tumor microenvironment in the design of a novel vascular-targeted gene therapy-based approach to the treatment of cancer,” International Journal of Radiation Oncology Biology Physics, vol. 54, no. 5, pp. 1473–1478, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. R. B. Pedley, E. El-Emir, A. A. Flynn et al., “Synergy between vascular targeting agents and antibody-directed therapy,” International Journal of Radiation Oncology Biology Physics, vol. 54, no. 5, pp. 1524–1531, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Wachsberger, R. Burd, and A. P. Dicker, “Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction,” Clinical Cancer Research, vol. 9, no. 6, pp. 1957–1971, 2003. View at Scopus
  47. A. Marconescu and P. E. Thorpe, “Coincident exposure of phosphatidylethanolamine and anionic phospholipids on the surface of irradiated cells,” Biochimica et Biophysica Acta, vol. 1778, no. 10, pp. 2217–2224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Ran and P. E. Thorpe, “Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy,” International Journal of Radiation Oncology Biology Physics, vol. 54, no. 5, pp. 1479–1484, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Balasubramanian and A. J. Schroit, “Aminophospholipid asymmetry: a matter of life and death,” Annual Review of Physiology, vol. 65, pp. 701–734, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Kuin, F. Citarella, Y. G. Oussoren, A. F. van der Wal, L. G. H. Dewit, and F. A. Stewart, “Increased glomerular Vwf after kidney irradiation is not due to increased biosynthesis or endothelial cell proliferation,” Radiation Research, vol. 156, no. 1, pp. 20–27, 2001. View at Scopus
  51. M. Verheij, L. G. H. Dewit, M. N. Boomgaard, H.-J. M. Brinkman, and J. A. van Mourik, “Ionizing radiation enhances platelet adhesion to the extracellular matrix of human endothelial cells by an increase in the release of von Willebrand factor,” Radiation Research, vol. 137, no. 2, pp. 202–207, 1994. View at Scopus
  52. B. Fadeel and D. Xue, “The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease,” Critical Reviews in Biochemistry and Molecular Biology, vol. 44, no. 5, pp. 264–277, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. J. H. Jandl, Blood: Textbook of Hematology, Little, Brown and Company, Boston, Mass, USA, 1st edition, 1996.
  54. Y. Ebisawa, T. Kono, M. Yoneda et al., “Direct evidence that induced nitric oxide production in hepatocytes prevents liver damage during lipopolysaccharide tolerance in rats,” Journal of Surgical Research, vol. 118, no. 2, pp. 183–189, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Gao, B. X. Zeng, L. J. Zhou, and S. Y. Yuan, “Protective effects of early treatment with propofol on endotoxin-induced acute lung injury in rats,” British Journal of Anaesthesia, vol. 92, no. 2, pp. 277–279, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. J. C. Meltzer, B. J. MacNeil, V. Sanders et al., “Contribution of the adrenal glands and splenic nerve to LPS-induced splenic cytokine production in the rat,” Brain, Behavior, and Immunity, vol. 17, no. 6, pp. 482–497, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Philipp, A. Dienst, M. Unruh et al., “Soluble tissue factor induces coagulation on tumor endothelial cells in vivo if coadministered with low-dose lipopolysaccharides,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 5, pp. 905–910, 2003. View at Publisher · View at Google Scholar · View at Scopus